
Aditxt
Pre-clinical stage, life sciences company with a mission to prolong life and enhance life quality of transplanted patients.
Market cap
$3.2m
Enterprise value
$7m
Share price
$1.28 ADTX
Recent deals
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | - | - | 789 % | (31 %) | (79 %) |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | (601 %) | - | - | (25664 %) | (2601 %) | (3954 %) | (20490 %) |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | (609 %) | - | - | (44149 %) | (2961 %) | (5019 %) | (25709 %) |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | 56 % | - | - | 4801 % | 778 % | 1096 % | 8125 % |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Aditxt
Edit
ACQUISITION by Aditxt Apr 2024

ACQUISITION by Aditxt Dec 2021

ACQUISITION by Aditxt Dec 2023

ACQUISITION by Aditxt Oct 2021